Takeya showed an association between LN resident CD169+ sinus macrophages (LySMs) and higher tumour infiltrating lymphocyte (TIL) counts in patients after neoadjuvant therapy, suggesting host immune reactivity induced by cancer cell phagocytosis by LySMs [51]. The gene discussed is SIGLEC1; the disease is neoplasm.